HUTCHMED (China) Statistics
Total Valuation
HCM has a market cap or net worth of $2.63 billion. The enterprise value is $1.83 billion.
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, before market open.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HCM has 854.88 million shares outstanding. The number of shares has increased by 0.42% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 854.88M |
| Shares Change (YoY) | +0.42% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 504.61M |
Valuation Ratios
The trailing PE ratio is 69.75 and the forward PE ratio is 10.24.
| PE Ratio | 69.75 |
| Forward PE | 10.24 |
| PS Ratio | 4.18 |
| Forward PS | n/a |
| PB Ratio | 3.41 |
| P/TBV Ratio | 3.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 5,294.95 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 48.50 |
| EV / Sales | 2.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.83 |
| Quick Ratio | 2.68 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.22 |
Financial Efficiency
Return on equity (ROE) is 5.04% and return on invested capital (ROIC) is -3.23%.
| Return on Equity (ROE) | 5.04% |
| Return on Assets (ROA) | -2.14% |
| Return on Invested Capital (ROIC) | -3.23% |
| Return on Capital Employed (ROCE) | -4.87% |
| Revenue Per Employee | $347,985 |
| Profits Per Employee | $20,833 |
| Employee Count | 1,811 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 11.15 |
Taxes
In the past 12 months, HCM has paid $7.19 million in taxes.
| Income Tax | 7.19M |
| Effective Tax Rate | 15.85% |
Stock Price Statistics
The stock price has decreased by -14.21% in the last 52 weeks. The beta is 0.61, so HCM's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -14.21% |
| 50-Day Moving Average | 14.72 |
| 200-Day Moving Average | 15.92 |
| Relative Strength Index (RSI) | 51.85 |
| Average Volume (20 Days) | 94,968 |
Short Selling Information
| Short Interest | 478,193 |
| Short Previous Month | 437,335 |
| Short % of Shares Out | 0.47% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.55 |
Income Statement
In the last 12 months, HCM had revenue of $630.20 million and earned $37.73 million in profits. Earnings per share was $0.04.
| Revenue | 630.20M |
| Gross Profit | 69.21M |
| Operating Income | -43.71M |
| Pretax Income | -37.31M |
| Net Income | 37.73M |
| EBITDA | -31.36M |
| EBIT | -43.71M |
| Earnings Per Share (EPS) | $0.04 |
Full Income StatementBalance Sheet
The company has $838.76 million in cash and $89.82 million in debt, giving a net cash position of $748.94 million or $0.88 per share.
| Cash & Cash Equivalents | 838.76M |
| Total Debt | 89.82M |
| Net Cash | 748.94M |
| Net Cash Per Share | $0.88 |
| Equity (Book Value) | 771.85M |
| Book Value Per Share | 0.89 |
| Working Capital | 689.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $497,000 and capital expenditures -$17.93 million, giving a free cash flow of -$17.44 million.
| Operating Cash Flow | 497,000 |
| Capital Expenditures | -17.93M |
| Free Cash Flow | -17.44M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 10.98%, with operating and profit margins of -6.94% and 5.99%.
| Gross Margin | 10.98% |
| Operating Margin | -6.94% |
| Pretax Margin | 7.20% |
| Profit Margin | 5.99% |
| EBITDA Margin | -4.98% |
| EBIT Margin | -6.94% |
| FCF Margin | n/a |
Dividends & Yields
HCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.42% |
| Shareholder Yield | -0.42% |
| Earnings Yield | 1.43% |
| FCF Yield | -0.66% |
Dividend DetailsAnalyst Forecast
The average price target for HCM is $19.00, which is 22.98% higher than the current price. The consensus rating is "Hold".
| Price Target | $19.00 |
| Price Target Difference | 22.98% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 22.58% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCM has an Altman Z-Score of 3.68 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.68 |
| Piotroski F-Score | 3 |
